| Dr Samuel P Nelson, DO | |
|
9300 Dewitt Loop, Fort Belvoir, VA 22060-5285 | |
| (571) 231-6617 | |
| Not Available |
| Full Name | Dr Samuel P Nelson |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 9300 Dewitt Loop, Fort Belvoir, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730643180 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 0102206417 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Samuel P Nelson, DO 9300 Dewitt Loop, Fort Belvoir, VA 22060-5285 Ph: () - | Dr Samuel P Nelson, DO 9300 Dewitt Loop, Fort Belvoir, VA 22060-5285 Ph: (571) 231-6617 |
News Archive
Researchers report new insights into how the brain responds to extreme stress, whether from combat, natural disasters, or repeated violent competition. The insights offer hope for detecting and treating several widespread and debilitating neuropsychiatric disorders, and were presented at Neuroscience 2012, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.
The gridlock is over how to pay for the fix and could threaten the broader legislative package, which includes the payroll tax break extension. Meanwhile, lawmakers examine familiar offset possibilities, as well as some ideas from the private sector.
This study provided important data about the fertility window of women who had suffered from childhood cancer and information concerning the associated risk factors, but did not confirm the greater risk of premature menopause (before the age of 40) that was reported by the American studies.
Treatment strategies for diabetic macular oedema have evolved over the past decade, with focal laser therapy being largely replaced by intravitreal injections, an observational case series of more than 1500 patients shows.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc., a Nevada Corporation, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 50 mg, 100 mg, 150mg, 200 mg, and 250mg strength armodafinil tablets prior to the expiration of patents owned by Cephalon France.
› Verified 3 days ago
Dr. Sarah Elizabeth Condon, MD General Practice Medicare: Medicare Enrolled Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 571-231-0264 | |
Dr. Michael Paul Szczepanski, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 253-968-2997 | |
Timothy Groh, General Practice Medicare: Not Enrolled in Medicare Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 571-231-3224 | |
Dr. Ida S Sanchez-pica, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 9501 Farrell Rd, Fort Belvoir, VA 22060 Phone: 703-805-0536 Fax: 703-805-0512 | |
Dr. Merritt Elise Ware, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 571-231-3442 | |
Dr. Paul Isaiah Moss, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 937-542-1524 | |
Dr. Nicolas Brandon Moya Del Pino, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 571-231-1789 |